Sherif Dabash, MD
Orthopedic Surgery · Tucson, AZNPI 1750820734
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,921 of the $11,492 with a category attached, or 60.2%. 10 manufacturers reported payments, led by Arthrex at 45.9% of the total. Reporting peaked in 2024 at $4,679 and has fallen 63.7% since, to $1,700 in 2025.
Across 90 payments — averaging $127.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Stryker$4K
- Mid-atlantic Surgical Systems, LLC$2K
- MVP Orthopedics Inc$363
- Zimmer Biomet$60
- Boston Scientific$58
- plus $86 from 4 others
What the payments were for
- Travel & lodging$6,92160%
- Food & beverage$2,17119%
- Education$2,40021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 43 | $5,275 |
| Stryker | 29 | $3,716 |
| Mid-atlantic Surgical Systems, LLC | 8 | $1,935 |
| MVP Orthopedics Inc | 2 | $363 |
| Zimmer Biomet | 1 | $60 |
| Boston Scientific | 3 | $58 |
| Linvatec Corporation | 1 | $43 |
| Organogenesis Inc. | 1 | $18 |
| Bioventus LLC | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopedic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $596 |
| Ciprofloxacin Hcl | 28 | $385 |
| Cefdinir | 14 | $311 |
| Meloxicam | 100 | $212 |
| Oxycodone Hcl | 59 | $177 |
| Doxycycline Hyclate | 14 | $123 |
| Cephalexin | 14 | $117 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Tucson
- Christopher YeungPhoenix$2.7M
- Michael LeePhoenix$6K
- Gregory PeareYuma$4K
- Christopher HamiltonScottsdale$4K
- Michael WengPhoenix$2K
- Randall HardisonChandler$1K
- Andre MatthewsMesa$180
- Sepein ChiangPhoenix$0
- Leonard BodellPhoenix$0
- Janet WhirlowScottsdale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.